Veritone stock price target raised to $9 from $6 at H.C. Wainwright

Investing.comMonday, October 20, 2025 at 11:38:59 AM
Veritone stock price target raised to $9 from $6 at H.C. Wainwright
Veritone's stock price target has been raised from $6 to $9 by H.C. Wainwright, signaling increased confidence in the company's future performance. This adjustment reflects the analysts' positive outlook on Veritone's growth potential and could attract more investors, boosting the stock's value.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
H.C. Wainwright reiterates Buy rating on Evaxion Biotech stock with $16 target
PositiveFinancial Markets
H.C. Wainwright has reaffirmed its Buy rating on Evaxion Biotech, setting a target price of $16 for the stock. This endorsement highlights the firm's confidence in Evaxion's potential for growth and innovation in the biotech sector, which is crucial for investors looking for promising opportunities in healthcare.
H.C. Wainwright reiterates Buy rating on Agenus stock after promising ESMO data
PositiveFinancial Markets
H.C. Wainwright has reaffirmed its Buy rating on Agenus stock following encouraging data presented at the ESMO conference. This positive outlook is significant as it reflects confidence in Agenus' potential in the biotech sector, which could attract more investors and drive the stock price higher. The promising results from ESMO could pave the way for future developments and partnerships, making it an exciting time for both the company and its shareholders.
Corbus Pharmaceuticals stock reaffirmed as Buy by H.C. Wainwright
PositiveFinancial Markets
Corbus Pharmaceuticals has received a positive reaffirmation from H.C. Wainwright, which has maintained its 'Buy' rating on the company's stock. This endorsement is significant as it reflects confidence in Corbus's potential for growth and success in the pharmaceutical market, particularly in developing innovative treatments. Investors may view this as a strong signal to consider Corbus as a viable investment opportunity.
H.C. Wainwright reiterates Buy rating on Altimmune stock ahead of key 4Q25 catalysts
PositiveFinancial Markets
H.C. Wainwright has reaffirmed its Buy rating on Altimmune stock, highlighting the company's promising potential ahead of significant catalysts expected in the fourth quarter of 2025. This endorsement is crucial as it reflects confidence in Altimmune's growth prospects and could attract more investors, especially as the company approaches key developments that may impact its market performance.
Latest from Financial Markets
Earnings call transcript: Zions Q3 2025 beats EPS and revenue forecasts
PositiveFinancial Markets
Zions Bancorporation has reported impressive earnings for the third quarter of 2025, surpassing both earnings per share (EPS) and revenue forecasts. This positive performance highlights the bank's strong financial health and effective management strategies, which are crucial for maintaining investor confidence and supporting future growth. Such results not only reflect the bank's resilience in a competitive market but also indicate a promising outlook for the financial sector as a whole.
BHP’s iron ore production misses estimates on hit from maintenance works
NegativeFinancial Markets
BHP's recent report reveals that its iron ore production has fallen short of estimates due to maintenance works, raising concerns among investors. This shortfall could impact the company's financial performance and market position, highlighting the challenges faced in maintaining operational efficiency. As one of the largest mining companies globally, BHP's production levels are closely watched, and any deviations can influence commodity prices and investor confidence.
Soybeans Are a Major Point of Leverage: Jeff Moon
NeutralFinancial Markets
Jeff Moon, the former Assistant U.S. Trade Representative to China, highlights the significant leverage China now holds over rare earth materials, a situation that could reshape U.S.-China relations. He discusses this on 'The Close' with Katie Greifeld and Romaine Bostick, suggesting that both nations are on the brink of a new era in trade dynamics. This is important as it could impact global supply chains and economic strategies moving forward.
Dageville, Snowflake founder, sells $6.15m in SNOW stock
NeutralFinancial Markets
Dageville, the founder of Snowflake, has sold $6.15 million worth of SNOW stock, a move that has caught the attention of investors and analysts alike. This sale is significant as it may indicate Dageville's confidence in the company's future or a strategic financial decision. Understanding the implications of such stock sales can provide insights into market trends and investor sentiment.
Daily Market Wrap - Top Stocks: Apple, Netflix and CoreWeave
PositiveFinancial Markets
Despite an Amazon Web Services outage that caused some disruptions, Wall Street experienced a significant surge, with the S&P 500 rising by 1.1%. This positive momentum was largely driven by strong performances from Apple and a general optimism as investors look forward to a busy earnings week. The resilience of the market in the face of challenges highlights the confidence investors have in leading tech stocks.
Trump administration weighing Fannie, Freddie offering as soon as end-2025, FHFA director says
NeutralFinancial Markets
The Trump administration is considering a potential offering for Fannie Mae and Freddie Mac, with the Federal Housing Finance Agency (FHFA) director indicating that this could happen as early as the end of 2025. This development is significant as it could reshape the housing finance landscape, impacting mortgage rates and availability for homebuyers. Stakeholders in the housing market are closely monitoring these discussions, as changes could influence both the economy and individual homeowners.